AllTopicsTodayAllTopicsToday
Notification
Font ResizerAa
  • Home
  • Tech
  • Investing & Finance
  • AI
  • Entertainment
  • Wellness
  • Gaming
  • Movies
Reading: Prescient Therapeutics Limited (PSTTF) Discusses Clinical Progress of PTX-100 in Cancer Trials and Regulatory Milestones Transcript
Share
Font ResizerAa
AllTopicsTodayAllTopicsToday
  • Home
  • Blog
  • About Us
  • Contact
Search
  • Home
  • Tech
  • Investing & Finance
  • AI
  • Entertainment
  • Wellness
  • Gaming
  • Movies
Have an existing account? Sign In
Follow US
©AllTopicsToday 2026. All Rights Reserved.
AllTopicsToday > Blog > Investing & Finance > Prescient Therapeutics Limited (PSTTF) Discusses Clinical Progress of PTX-100 in Cancer Trials and Regulatory Milestones Transcript
Og image 1200 29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png
Investing & Finance

Prescient Therapeutics Limited (PSTTF) Discusses Clinical Progress of PTX-100 in Cancer Trials and Regulatory Milestones Transcript

AllTopicsToday
Last updated: October 20, 2025 4:42 am
AllTopicsToday
Published: October 20, 2025
Share
SHARE

Christian Riedel

Hi there everybody. Welcome to the PTX Investor Briefing. Till folks get used to it, I am going to simply give a fast disclaimer concerning the session.

The displays we host are appropriate for self-directed traders with the expertise and talent to make their very own knowledgeable choices. The knowledge contained in right this moment’s presentation is of a common nature and acceptable to you and doesn’t have in mind your personal private circumstances. The knowledge we offer is used for academic functions solely. Previous efficiency shouldn’t be a dependable indicator of future efficiency.

fantastic. So let’s begin the session. I am Christian Riedel, Government Director of Attain. I shall be moderating the session right this moment. A lot of you could know me from my latest fundraising. James and I’ve carried out fairly just a few webcasts to each shareholders and potential new traders. James is James McDonnell, CEO of Prescient. And right this moment’s replace follows the latest 4C announcement, together with an replace on the Part IIa research of PTX-100 in most cancers remedy with seven medical websites at the moment open in Australia and america.

The best way the session works is that I ask James just a few questions on latest information and up to date releases, after which I stroll him by means of the fabric. I believe it may be a mix of standard decks and shareholder assembly displays, reflecting a few of these new releases. Then we’ll observe up with some Q&A to see what we’ve not lined but and open the ground to the viewers right here to get the most recent info. We count on the next from the session:

Nintendo earnings Q1 2025
4 Best No-Appraisal Home Equity Loans of September 2025
Be Careful Sabotaging Your Retirement For Private Grade School
Alniri (alniri.com) program details. Reviews, Scam or Paying
‘Garbage Loans’; What A Prudent Investor Should Know
TAGGED:CancerClinicalDiscussesLimitedMilestonesPrescientProgressPSTTFPTX100regulatoryTherapeuticsTranscriptTrials
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Popular News
Codex open ai.jpg
AI

A look under the hood of Codex

AllTopicsToday
AllTopicsToday
February 1, 2026
The Self-Taught AI Redefines Computer Vision
The Shocking Power Of Getting A Different Perspective
Winners and Losers in a World Without Quarterly Earnings
Men, Loneliness, Anger And How Mindfulness Helps
- Advertisement -
Ad space (1)

Categories

  • Tech
  • Investing & Finance
  • AI
  • Entertainment
  • Wellness
  • Gaming
  • Movies

About US

We believe in the power of information to empower decisions, fuel curiosity, and spark innovation.
Quick Links
  • Home
  • Blog
  • About Us
  • Contact
Important Links
  • About Us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • Contact

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

©AllTopicsToday 2026. All Rights Reserved.
1 2
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?